awacke1/LOINC-Clinical-Terminology · Datasets at Hugging Face

LOINC_NUM stringlengths 3 8	COMPONENT stringlengths 2 246	PROPERTY stringlengths 1 29	TIME_ASPCT stringlengths 1 15	SYSTEM stringlengths 1 106	SCALE_TYP stringclasses 10 values	METHOD_TYP stringlengths 1 57 ⌀	CLASS stringlengths 2 24	CLASSTYPE int64 1 4	LONG_COMMON_NAME stringlengths 3 254	SHORTNAME stringlengths 2 51 ⌀	EXTERNAL_COPYRIGHT_NOTICE stringlengths 39 2.6k ⌀	STATUS stringclasses 4 values	VersionFirstReleased stringlengths 1 7	VersionLastChanged stringlengths 1 5
90807-9	Candida glabrata DNA	PrThr	Pt	Ser	Ord	Probe.amp.tar	MICRO	1	Candida glabrata DNA [Presence] in Serum by NAA with probe detection	C glabrata DNA Ser Ql NAA+probe	null	ACTIVE	2.65	2.65
90808-7	Candida krusei DNA	PrThr	Pt	Ser	Ord	Probe.amp.tar	MICRO	1	Candida krusei DNA [Presence] in Serum by NAA with probe detection	C krusei DNA Ser Ql NAA+probe	null	ACTIVE	2.65	2.65
90809-5	Candida parapsilosis DNA	PrThr	Pt	Ser	Ord	Probe.amp.tar	MICRO	1	Candida parapsilosis DNA [Presence] in Serum by NAA with probe detection	C parap DNA Ser Ql NAA+probe	null	ACTIVE	2.65	2.65
90810-3	Candida tropicalis DNA	PrThr	Pt	Ser	Ord	Probe.amp.tar	MICRO	1	Candida tropicalis DNA [Presence] in Serum by NAA with probe detection	C tropicls DNA Ser Ql NAA+probe	null	ACTIVE	2.65	2.65
9081-1	Protein intake	MRat	1H	^Patient	Qn	null	IO_IN_SALTS+CALS	2	Protein intake 1 hour	Protein intake 1h	null	ACTIVE	1.0i	2.48
90811-1	Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptor 1 Ab	PrThr	Pt	CSF	Ord	CBA IFA	SERO	1	AMPAR1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay	AMPAR1 Ab CSF Ql CBA IFA	null	ACTIVE	2.65	2.69
90812-9	Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptor 1 Ab	Titr	Pt	CSF	Qn	CBA IFA	SERO	1	AMPAR1 Ab [Titer] in Cerebral spinal fluid by Cell binding immunofluorescent assay	AMPAR1 Ab Titr CSF CBA IFA	null	ACTIVE	2.65	2.69
90813-7	Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptor 2 Ab	PrThr	Pt	CSF	Ord	CBA IFA	SERO	1	AMPAR2 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay	AMPAR2 Ab CSF Ql CBA IFA	null	ACTIVE	2.65	2.69
90814-5	Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptor 2 Ab	Titr	Pt	CSF	Qn	CBA IFA	SERO	1	AMPAR2 Ab [Titer] in Cerebral spinal fluid by Cell binding immunofluorescent assay	AMPAR2 Ab Titr CSF CBA IFA	null	ACTIVE	2.65	2.69
90815-2	Amphiphysin Ab	PrThr	Pt	CSF	Ord	IF	SERO	1	Amphiphysin Ab [Presence] in Cerebral spinal fluid by Immunofluorescence	Amphiphysin Ab CSF Ql IF	null	ACTIVE	2.65	2.65
90816-0	Amphiphysin Ab	ACnc	Pt	CSF	Qn	Line blot	SERO	1	Amphiphysin Ab [Units/volume] in Cerebral spinal fluid by Line blot	Amphiphysin Ab CSF Line blot-aCnc	null	ACTIVE	2.65	2.7
90817-8	Aquaporin 4 water channel Ab	PrThr	Pt	CSF	Ord	IF	SERO	1	Aquaporin 4 water channel Ab [Presence] in Cerebral spinal fluid by Immunofluorescence	AQP4 H2O channel Ab CSF Ql IF	null	ACTIVE	2.65	2.67
90818-6	Aquaporin 4 water channel Ab.IgG	PrThr	Pt	CSF	Ord	CBA IFA	SERO	1	Aquaporin 4 water channel IgG Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay	AQP4 H2O channel IgG CSF Ql CBA IFA	null	ACTIVE	2.65	2.69
90819-4	Aquaporin 4 water channel Ab.IgG	Titr	Pt	CSF	Qn	CBA IFA	SERO	1	Aquaporin 4 water channel IgG Ab [Titer] in Cerebral spinal fluid by Cell binding immunofluorescent assay	AQP4 H2O channel IgG Titr CSF CBA IFA	null	ACTIVE	2.65	2.69
90820-2	Contactin-associated protein 2 Ab	PrThr	Pt	CSF	Ord	CBA IFA	SERO	1	Contactin-associated protein 2 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay	CASPR2 Ab CSF Ql CBA IFA	null	ACTIVE	2.65	2.69
90821-0	Contactin-associated protein 2 Ab	Titr	Pt	CSF	Qn	CBA IFA	SERO	1	Contactin-associated protein 2 Ab [Titer] in Cerebral spinal fluid by Cell binding immunofluorescent assay	CASPR2 Ab Titr CSF CBA IFA	null	ACTIVE	2.65	2.69
90822-8	CV2 Ab	ACnc	Pt	CSF	Qn	Line blot	SERO	1	CV2 Ab [Units/volume] in Cerebral spinal fluid by Line blot	CV2 Ab CSF Line blot-aCnc	null	ACTIVE	2.65	2.7
90823-6	Dipeptidyl aminopeptidase-like protein 6 Ab	PrThr	Pt	CSF	Ord	CBA IFA	SERO	1	Dipeptidyl aminopeptidase-like protein 6 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay	DPPX Ab CSF Ql CBA IFA	null	ACTIVE	2.65	2.69
90824-4	Dipeptidyl aminopeptidase-like protein 6 Ab	Titr	Pt	CSF	Qn	CBA IFA	SERO	1	Dipeptidyl aminopeptidase-like protein 6 Ab [Titer] in Cerebral spinal fluid by Cell binding immunofluorescent assay	DPPX Ab Titr CSF CBA IFA	null	ACTIVE	2.65	2.69
90825-1	Gamma aminobutyrate B receptor Ab	PrThr	Pt	CSF	Ord	CBA IFA	SERO	1	GABABR Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay	GABABR Ab CSF Ql CBA IFA	null	ACTIVE	2.65	2.69
90826-9	Gamma aminobutyrate B receptor Ab	Titr	Pt	CSF	Qn	CBA IFA	SERO	1	GABABR Ab [Titer] in Cerebral spinal fluid by Cell binding immunofluorescent assay	GABABR Ab Titr CSF CBA IFA	null	ACTIVE	2.65	2.69
90827-7	Glial nuclear type 1 Ab	PrThr	Pt	CSF	Ord	IF	SERO	1	Glial nuclear type 1 Ab [Presence] in Cerebral spinal fluid by Immunofluorescence	Glial nuc type 1 Ab CSF Ql IF	null	ACTIVE	2.65	2.65
90828-5	Glial nuclear type 1 Ab	ACnc	Pt	CSF	Qn	Line blot	SERO	1	Glial nuclear type 1 Ab [Units/volume] in Cerebral spinal fluid by Line blot	Glial nuc type 1 Ab CSF Line blot-aCnc	null	ACTIVE	2.65	2.7
9082-9	Protein intake	MRat	8H	^Patient	Qn	null	IO_IN_SALTS+CALS	2	Protein intake 8 hour	Protein intake 8h	null	ACTIVE	1.0i	2.48
90829-3	Glutamate decarboxylase 65 Ab	ACnc	Pt	CSF	Qn	Line blot	SERO	1	Glutamate decarboxylase 65 Ab [Units/volume] in Cerebral spinal fluid by Line blot	GAD65 Ab CSF Line blot-aCnc	null	ACTIVE	2.65	2.7
90830-1	Leucine-rich glioma-inactivated protein 1 Ab	PrThr	Pt	CSF	Ord	CBA IFA	SERO	1	Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay	LGI1 Ab CSF Ql CBA IFA	null	ACTIVE	2.65	2.69
90831-9	Leucine-rich glioma-inactivated protein 1 Ab	Titr	Pt	CSF	Qn	CBA IFA	SERO	1	Leucine-rich glioma-inactivated protein 1 Ab [Titer] in Cerebral spinal fluid by Cell binding immunofluorescent assay	LGI1 Ab Titr CSF CBA IFA	null	ACTIVE	2.65	2.69
90832-7	Ma+Ta Ab	PrThr	Pt	CSF	Ord	IF	SERO	1	Ma+Ta Ab [Presence] in Cerebral spinal fluid by Immunofluorescence	Ma+Ta Ab CSF Ql IF	null	ACTIVE	2.65	2.65
90833-5	Ma+Ta Ab	ACnc	Pt	CSF	Qn	Line blot	SERO	1	Ma+Ta Ab [Units/volume] in Cerebral spinal fluid by Line blot	Ma+Ta Ab CSF Line blot-aCnc	null	ACTIVE	2.65	2.7
90834-3	Myelin Ab	Titr	Pt	CSF	Qn	IF	SERO	1	Myelin Ab [Titer] in Cerebral spinal fluid by Immunofluorescence	Myelin Ab Titr CSF IF	null	ACTIVE	2.65	2.65
90835-0	Myelin associated glycoprotein Ab.IgM	PrThr	Pt	CSF	Ord	IB	SERO	1	Myelin associated glycoprotein IgM Ab [Presence] in Cerebral spinal fluid by Immunoblot	MAG IgM CSF Ql IB	null	ACTIVE	2.65	2.65
90836-8	Neuronal nuclear type 3 Ab	PrThr	Pt	CSF	Ord	IF	SERO	1	Neuronal nuclear type 3 Ab [Presence] in Cerebral spinal fluid by Immunofluorescence	Hu3 Ab CSF Ql IF	null	ACTIVE	2.65	2.65
9083-7	Protein intake	MRat	10H	^Patient	Qn	null	IO_IN_SALTS+CALS	2	Protein intake 10 hour	Protein intake 10h	null	ACTIVE	1.0i	2.48
90837-6	Neuronal nuclear type 3 Ab	Titr	Pt	CSF	Qn	IF	SERO	1	Neuronal nuclear type 3 Ab [Titer] in Cerebral spinal fluid by Immunofluorescence	Hu3 Ab Titr CSF IF	null	ACTIVE	2.65	2.65
90838-4	Neuronal nuclear type 3 Ab	ACnc	Pt	CSF	Qn	Line blot	SERO	1	Neuronal nuclear type 3 Ab [Units/volume] in Cerebral spinal fluid by Line blot	Hu3 Ab CSF Line blot-aCnc	null	ACTIVE	2.65	2.7
90839-2	N-methyl-D-aspartate receptor subunit 1 Ab	PrThr	Pt	CSF	Ord	CBA IFA	SERO	1	NMDAR subunit 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay	NMDAR1 Ab CSF Ql CBA IFA	null	ACTIVE	2.65	2.69
908-4	Ax Ab	PrThr	Pt	Ser/Plas^BPU	Ord	null	BLDBK	1	Ax Ab [Presence] in Serum or Plasma from Blood product unit	Ax Ab SerPl BPU Ql	null	ACTIVE	1.0	2.56
90840-0	N-methyl-D-aspartate receptor subunit 1 Ab	Titr	Pt	CSF	Qn	CBA IFA	SERO	1	NMDAR subunit 1 Ab [Titer] in Cerebral spinal fluid by Cell binding immunofluorescent assay	NMDAR1 Ab Titr CSF CBA IFA	null	ACTIVE	2.65	2.69
90841-8	Purkinje cell cytoplasmic type 1 Ab	PrThr	Pt	CSF	Ord	IF	SERO	1	PCA-1 Ab [Presence] in Cerebral spinal fluid by Immunofluorescence	PCA-1 Ab CSF Ql IF	null	ACTIVE	2.65	2.65
90842-6	Purkinje cell cytoplasmic type 1 Ab	ACnc	Pt	CSF	Qn	Line blot	SERO	1	PCA-1 Ab [Units/volume] in Cerebral spinal fluid by Line blot	PCA-1 Ab CSF Line blot-aCnc	null	ACTIVE	2.65	2.7
90843-4	Purkinje cell cytoplasmic type 2 Ab	PrThr	Pt	CSF	Ord	IF	SERO	1	PCA-2 Ab [Presence] in Cerebral spinal fluid by Immunofluorescence	PCA-2 Ab CSF Ql IF	null	ACTIVE	2.65	2.65
90844-2	Purkinje cell cytoplasmic type Tr Ab	PrThr	Pt	CSF	Ord	CBA IFA	SERO	1	PCA-Tr Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay	PCA-Tr Ab CSF Ql CBA IFA	null	ACTIVE	2.65	2.69
9084-5	Protein intake	MRat	12H	^Patient	Qn	null	IO_IN_SALTS+CALS	2	Protein intake 12 hour	Protein intake 12h	null	ACTIVE	1.0i	2.48
90845-9	Purkinje cell cytoplasmic type Tr Ab	PrThr	Pt	CSF	Ord	IF	SERO	1	PCA-Tr Ab [Presence] in Cerebral spinal fluid by Immunofluorescence	PCA-Tr Ab CSF Ql IF	null	ACTIVE	2.65	2.65
90846-7	Purkinje cell cytoplasmic type Tr Ab	Titr	Pt	CSF	Qn	CBA IFA	SERO	1	PCA-Tr Ab [Titer] in Cerebral spinal fluid by Cell binding immunofluorescent assay	PCA-Tr Ab Titr CSF CBA IFA	null	ACTIVE	2.65	2.69
90847-5	Zinc finger protein of the cerebellum 4 Ab	ACnc	Pt	CSF	Qn	Line blot	SERO	1	Zinc finger protein of the cerebellum 4 Ab [Units/volume] in Cerebral spinal fluid by Line blot	Zic4 Ab CSF Line blot-aCnc	null	ACTIVE	2.65	2.7
90848-3	Myelin associated glycoprotein-sulfated glucuronic paragloboside Ab.IgM	Titr	Pt	CSF	Qn	IA	SERO	1	Myelin associated glycoprotein/Sulfated glucuronic paragloboside IgM Ab [Titer] in Cerebral spinal fluid by Immunoassay	MAG/SGPG IgM Titr CSF IA	null	ACTIVE	2.65	2.65
90849-1	Cefpodoxime 4.0 ug/mL	Susc	Pt	Isolate	OrdQn	Method for Slow-growing mycobacteria	ABXBACT	1	Cefpodoxime 4 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria	Cefpodoxime 4 ug/mL Islt SlowMyco	null	ACTIVE	2.65	2.65
90850-9	cefTAZidime 1.0 ug/mL	Susc	Pt	Isolate	OrdQn	Method for Slow-growing mycobacteria	ABXBACT	1	cefTAZidime 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria	cefTAZidime 1 ug/mL Islt SlowMyco	null	ACTIVE	2.65	2.65
90851-7	GJB2 gene full mutation analysis	Find	Pt	Bld/Tiss	Doc	Sequencing	MOLPATH.MUT	1	GJB2 gene full mutation analysis in Blood or Tissue by Sequencing	GJB2 gene Full Mut Anl Bld/T Seq	null	ACTIVE	2.65	2.65
9085-2	Protein intake	MRat	24H	^Patient	Qn	null	IO_IN_SALTS+CALS	2	Protein intake 24 hour	Protein intake 24h	null	ACTIVE	1.0i	2.48
90852-5	Fax number	Tele	Pt	^Patient	Nom	null	ADMIN.PATIENT	2	Patient Fax number	Patient Fax #	null	ACTIVE	2.65	2.66
90853-3	Final score	Score	Pt	^Patient	Qn	DUKE-AD	SURVEY.DUKE-AD	4	Final score [DUKE-AD]	null	Copyright © 1994 Department of Community and Family Medicine, Duke University Medical Center, Durham, NC, USA. Used with permission.	ACTIVE	2.65	2.65
90854-1	Duke Anxiety Depression Scale	-	Pt	^Patient	-	DUKE-AD	PANEL.SURVEY.DUKE-AD	4	Duke Anxiety Depression Scale [DUKE-AD]	null	Copyright © 1994 Department of Community and Family Medicine, Duke University Medical Center, Durham, NC, USA. Used with permission.	ACTIVE	2.65	2.65
90855-8	Posterior inter-arch deviation	Type	Pt	Teeth and gum	Nom	null	DENTAL	2	Posterior inter-arch deviation Teeth and gum	Post inter-arch deviation Teeth+gum	null	ACTIVE	2.65	2.65
90856-6	Crossbite teeth	Num	Pt	Teeth and gum	Qn	null	DENTAL	2	Crossbite teeth [#]	Crossbite teeth	null	ACTIVE	2.65	2.65
90857-4	Closed-spaced teeth	Num	Pt	Teeth and gum	Qn	null	DENTAL	2	Closed-spaced teeth [#]	Closed-spaced teeth	null	ACTIVE	2.65	2.65
90858-2	Open-spaced teeth	Num	Pt	Teeth and gum	Qn	null	DENTAL	2	Open-spaced teeth [#]	Open-spaced teeth	null	ACTIVE	2.65	2.65
90859-0	Rotated teeth	Num	Pt	Teeth and gum	Qn	null	DENTAL	2	Rotated teeth [#]	Rotated teeth	null	ACTIVE	2.65	2.65
9086-0	Sodium intake	Sub	Pt	^Patient	Qn	Estimated	IO_IN_SALTS+CALS	2	Sodium intake Estimated	Sodium intake Est	null	ACTIVE	1.0i	2.48
90860-8	Crowded teeth	Num	Pt	Teeth and gum	Qn	null	DENTAL	2	Crowded teeth [#]	Crowded teeth	null	ACTIVE	2.65	2.65
90861-6	Missing teeth	Num	Pt	Teeth and gum	Qn	null	DENTAL	2	Missing teeth [#]	Missing teeth	null	ACTIVE	2.65	2.65
90862-4	Malocclusion index	Score	Pt	Teeth and gum	Qn	Calculated	DENTAL	2	Malocclusion index Teeth and gum Calculated	Malocclusion index Score Teeth+gum Calc	null	ACTIVE	2.65	2.65
90863-2	Labio-lingual spread	Len	Pt	Mouth	Qn	Measured	DENTAL	2	Labio-lingual spread [Length] Mouth Measured	Labio-lingual spread Mouth Measured	null	ACTIVE	2.65	2.65
90864-0	Dental abnormalities impacting orthodontic care	Find	Pt	Teeth and gum	Nom	null	DENTAL	2	Dental abnormalities impacting orthodontic care	Dental abnormalities orthodontic care	null	ACTIVE	2.65	2.65
90865-7	Craniofacial anomalies impacting orthodontic care	Find	Pt	Head	Nom	null	DENTAL	2	Craniofacial anomalies impacting orthodontic care	Craniofacial anomalies orthodontic care	null	ACTIVE	2.65	2.65
90866-5	Orthodontic preconditions	Find	Pt	^Patient	Nom	null	DENTAL	2	Orthodontic preconditions	Orthodontic preconditions	null	ACTIVE	2.65	2.65
90867-3	Airway problem impacting orthodontic treatment	Type	Pt	^Patient	Nom	null	DENTAL	2	Airway problem impacting orthodontic treatment	Airway prob impact orthodont trtmt	null	ACTIVE	2.65	2.65
90868-1	Orthognathic surgery consideration summary	Find	Pt	^Patient	Nar	null	DENTAL	2	Orthognathic surgery consideration summary Narrative	Orthognathic surg consideration summary	null	ACTIVE	2.65	2.65
90869-9	Asymmetry of lower face	Find	Pt	Face	Nom	null	DENTAL	2	Asymmetry of lower face	Asymmetry of lower face	null	ACTIVE	2.65	2.65
90870-7	Habits impacting orthodontic condition	Type	Pt	^Patient	Nom	null	DENTAL	2	Habits impacting orthodontic condition	Habits impact orthodontic cond	null	ACTIVE	2.65	2.65
90871-5	Medical conditions impacting orthodontic condition	Hx	Pt	^Patient	Nom	null	DENTAL	2	History of Medical conditions impacting orthodontic condition	Hx of Med cond impact orthodontic cond	null	ACTIVE	2.65	2.65
90872-3	Supplemental information about orthodontic condition	Find	Pt	Oral cavity	Doc	null	DENTAL	2	Supplemental information about orthodontic condition Oral cavity Document	Info orthodontic cond Oral cavity Doc	null	ACTIVE	2.65	2.65
90873-1	Malocclusion severity assessment	Find	Pt	Teeth and gum	Doc	null	DOC.MISC	2	Malocclusion severity assessment	Malocclusion severity assess Doc	null	ACTIVE	2.65	2.65
90874-9	Orthodontic evaluation summary	Find	Pt	^Patient	Doc	null	DOC.MISC	2	Orthodontic evaluation summary Document	Orthodontic eval summary Doc	null	ACTIVE	2.65	2.65
90875-6	Orthodontic service attachment	Find	Pt	{Setting}	Doc	{Role}	DOC.ADMIN	2	Orthodontic service attachment	Orthodontic service attach	null	ACTIVE	2.65	2.67
90876-4	Progress note	Find	Pt	{Setting}	Doc	Thromboembolism	DOC.ONTOLOGY	2	Thromboembolism Progress note	Thromboemb Prog note	null	ACTIVE	2.65	2.73
90877-2	Procedure note	Find	Pt	{Setting}	Doc	Thromboembolism	DOC.ONTOLOGY	2	Thromboembolism procedure note	Thromboemb Procedure note	null	ACTIVE	2.65	2.65
9087-8	Sodium intake	Sub	Pt	^Patient	Qn	Measured	IO_IN_SALTS+CALS	2	Sodium intake Measured	Sodium intake Measured	null	ACTIVE	1.0i	2.48
90878-0	Note	Find	Pt	Telephone encounter	Doc	Thromboembolism	DOC.ONTOLOGY	2	Thromboembolism Telephone encounter Note	Thromboemb Phone Note	null	ACTIVE	2.65	2.65
90879-8	Conference note	Find	Pt	{Setting}	Doc	Thromboembolism.team	DOC.ONTOLOGY	2	Thromboembolism Team Conference note	Thromboemb Team Conf eval note	null	ACTIVE	2.65	2.65
90880-6	Arachis hypogaea recombinant (rAra h) 6 Ab.IgE	ACnc	Pt	Ser	Qn	null	ALLERGY	1	Peanut recombinant (rAra h) 6 IgE Ab [Units/volume] in Serum	Peanut (rAra h) 6 IgE Qn	null	ACTIVE	2.65	2.73
90881-4	(Alternaria tenuis+Artemisia vulgaris+Betula verrucosa+Cladosporium herbarum+Phleum pratense) Ab.IgE	PrThr	Pt	Ser	Ord	Multidisk	ALLERGY	1	Inhalant Allergen Mix 6 (Alternaria tenuis+Mugwort+Silver birch+Cladosporium herbarum+Timothy grass) IgE Ab [Presence] in Serum by Multidisk	Inhalant Allerg Mix 6 IgE Ql	null	ACTIVE	2.65	2.65
90882-2	Staphylococcus aureus enterotoxin E Ab.IgE.RAST class	PrThr	Pt	Ser	Ord	null	ALLERGY	1	Staphylococcus aureus enterotoxin E IgE Ab RAST class [Presence] in Serum	S aureus Etx E IgE RAST Ql	null	ACTIVE	2.65	2.65
90883-0	PROMIS pediatric item bank - mobility - version 2.0	-	Pt	^Patient	-	PROMIS.PEDS	PANEL.SURVEY.PROMIS	4	PROMIS pediatric item bank - mobility - version 2.0	null	Copyright © 2010 PROMIS Health Organization or other individuals/entities that have contributed information and materials to Assessment Center, and are being used with the permission of the copyright holders. Use of PROMIS instruments (e.g., item banks, short forms, profile measures) are subject to the PROMIS Terms and Conditions available at: http://www.assessmentcenter.net/TandC.aspx	ACTIVE	2.65	2.65
90884-8	PROMIS pediatric mobility - version 2.0 T-Score	Tscore	Pt	^Patient	Qn	PROMIS.PEDS	SURVEY.PROMIS	4	PROMIS pediatric mobility - version 2.0 T-score	null	Copyright © 2010 PROMIS Health Organization or other individuals/entities that have contributed information and materials to Assessment Center, and are being used with the permission of the copyright holders. Use of PROMIS instruments (e.g., item banks, short forms, profile measures) are subject to the PROMIS Terms and Conditions available at: http://www.assessmentcenter.net/TandC.aspx	ACTIVE	2.65	2.65
90885-5	Influenza virus D RNA	ThreshNum	Pt	XXX	Qn	Probe.amp.tar	MICRO	1	Influenza virus D RNA [Cycle Threshold #] in Specimen by NAA with probe detection	FLUDV RNA Ct Spec Qn NAA+probe	null	ACTIVE	2.65	2.69
9088-6	Sodium intake	SRat	1H	^Patient	Qn	null	IO_IN_SALTS+CALS	2	Sodium intake 1 hour	Sodium intake 1h	null	ACTIVE	1.0i	2.48
90886-3	Influenza virus B RNA	ThreshNum	Pt	XXX	Qn	Probe.amp.tar	MICRO	1	Influenza virus B RNA [Cycle Threshold #] in Specimen by NAA with probe detection	FLUBV RNA Ct Spec Qn NAA+probe	null	ACTIVE	2.65	2.69
90887-1	Porcine circovirus type 3 ORF2 gene	Seq	Pt	Isolate	Nom	Sequencing	MICRO	1	Porcine circovirus type 3 ORF2 gene [Nucleotide sequence] in Isolate by Sequencing	PCV 3 ORF2 gene Islt-Seq	null	ACTIVE	2.65	2.65
90888-9	Porcine circovirus type 3 DNA	NCnc	Pt	XXX	Qn	Probe.amp.tar	MICRO	1	Porcine circovirus type 3 DNA [#/volume] (viral load) in Specimen by NAA with probe detection	PCV3 DNA # Spec NAA+probe	null	ACTIVE	2.65	2.69
90889-7	Porcine circovirus type 2 Ab.IgG	Titr	Pt	XXX	Qn	IF	MICRO	1	Porcine circovirus type 2 IgG Ab [Titer] in Specimen by Immunofluorescence	PCV2 IgG Titr Spec IF	null	ACTIVE	2.65	2.69
90890-5	Benzodiazepines panel	-	Pt	Urine	-	Confirm	PANEL.DRUG/TOX	1	Benzodiazepines panel - Urine by Confirmatory method	Benzodiazepines Pnl Ur Cfm	null	ACTIVE	2.65	2.65
90891-3	Estradiol^2H post XXX challenge	MCnc	Pt	Ser/Plas	Qn	null	CHAL	1	Estradiol (E2) [Mass/volume] in Serum or Plasma --2 hours post XXX challenge	Estradiol 2h p chal SerPl-mCnc	null	ACTIVE	2.65	2.65
90892-1	Borrelia sp panel	-	Pt	Bld	-	Non-probe.amp.tar	PANEL.MICRO	1	Borrelia sp panel - Blood by NAA with non-probe detection	B sp panel Bld NAA+non-probe	null	ACTIVE	2.65	2.68
90893-9	Borrelia burgdorferi bba64 gene	PrThr	Pt	Bld	Ord	Non-probe.amp.tar	MICRO	1	Borrelia burgdorferi bba64 gene [Presence] in Blood by NAA with non-probe detection	B burg bba64 gene Bld Ql NAA+non-probe	null	ACTIVE	2.65	2.65
9089-4	Sodium intake	SRat	8H	^Patient	Qn	null	IO_IN_SALTS+CALS	2	Sodium intake 8 hour	Sodium intake 8h	null	ACTIVE	1.0i	2.48
90894-7	Noroxymorphone	MCnc	Pt	Urine	Qn	Confirm	DRUG/TOX	1	Noroxymorphone [Mass/volume] in Urine by Confirmatory method	Noroxymorphone Ur Cfm-mCnc	null	ACTIVE	2.65	2.65
90895-4	Task identifier	ID	Pt	^Event	Nom	null	ADMIN.ID	2	Task identifier	Task ID	null	ACTIVE	2.65	2.68
90896-2	Person assigned to task	Pn	Pt	Personnel	Nom	null	ADMIN	2	Personnel Person assigned to task	Personnel Person assigned to task	null	ACTIVE	2.65	2.68

90807-9

Candida glabrata DNA

PrThr

Pt

Ser

Ord

Probe.amp.tar

MICRO

1

Candida glabrata DNA [Presence] in Serum by NAA with probe detection

C glabrata DNA Ser Ql NAA+probe

null

ACTIVE

2.65

90808-7

Candida krusei DNA

PrThr

Pt

Ser

Ord

Probe.amp.tar

MICRO

1

Candida krusei DNA [Presence] in Serum by NAA with probe detection

C krusei DNA Ser Ql NAA+probe

null

ACTIVE

2.65

90809-5

Candida parapsilosis DNA

PrThr

Pt

Ser

Ord

Probe.amp.tar

MICRO

1

Candida parapsilosis DNA [Presence] in Serum by NAA with probe detection

C parap DNA Ser Ql NAA+probe

null

ACTIVE

2.65

90810-3

Candida tropicalis DNA

PrThr

Pt

Ser

Ord

Probe.amp.tar

MICRO

1

Candida tropicalis DNA [Presence] in Serum by NAA with probe detection

C tropicls DNA Ser Ql NAA+probe

null

ACTIVE

2.65

9081-1

Protein intake

MRat

1H

^Patient

Qn

null

IO_IN_SALTS+CALS

2

Protein intake 1 hour

Protein intake 1h

null

ACTIVE

1.0i

2.48

90811-1

Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptor 1 Ab

PrThr

Pt

CSF

Ord

CBA IFA

SERO

1

AMPAR1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

AMPAR1 Ab CSF Ql CBA IFA

null

ACTIVE

2.65

2.69

90812-9

Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptor 1 Ab

Titr

Pt

CSF

Qn

CBA IFA

SERO

1

AMPAR1 Ab [Titer] in Cerebral spinal fluid by Cell binding immunofluorescent assay

AMPAR1 Ab Titr CSF CBA IFA

null

ACTIVE

2.65

2.69

90813-7

Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptor 2 Ab

PrThr

Pt

CSF

Ord

CBA IFA

SERO

1

AMPAR2 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

AMPAR2 Ab CSF Ql CBA IFA

null

ACTIVE

2.65

2.69

90814-5

Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptor 2 Ab

Titr

Pt

CSF

Qn

CBA IFA

SERO

1

AMPAR2 Ab [Titer] in Cerebral spinal fluid by Cell binding immunofluorescent assay

AMPAR2 Ab Titr CSF CBA IFA

null

ACTIVE

2.65

2.69

90815-2

Amphiphysin Ab

PrThr

Pt

CSF

Ord

IF

SERO

1

Amphiphysin Ab [Presence] in Cerebral spinal fluid by Immunofluorescence

Amphiphysin Ab CSF Ql IF

null

ACTIVE

2.65

90816-0

Amphiphysin Ab

ACnc

Pt

CSF

Qn

Line blot

SERO

1

Amphiphysin Ab [Units/volume] in Cerebral spinal fluid by Line blot

Amphiphysin Ab CSF Line blot-aCnc

null

ACTIVE

2.65

2.7

90817-8

Aquaporin 4 water channel Ab

PrThr

Pt

CSF

Ord

IF

SERO

1

Aquaporin 4 water channel Ab [Presence] in Cerebral spinal fluid by Immunofluorescence

AQP4 H2O channel Ab CSF Ql IF

null

ACTIVE

2.65

2.67

90818-6

Aquaporin 4 water channel Ab.IgG

PrThr

Pt

CSF

Ord

CBA IFA

SERO

1

Aquaporin 4 water channel IgG Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

AQP4 H2O channel IgG CSF Ql CBA IFA

null

ACTIVE

2.65

2.69

90819-4

Aquaporin 4 water channel Ab.IgG

Titr

Pt

CSF

Qn

CBA IFA

SERO

1

Aquaporin 4 water channel IgG Ab [Titer] in Cerebral spinal fluid by Cell binding immunofluorescent assay

AQP4 H2O channel IgG Titr CSF CBA IFA

null

ACTIVE

2.65

2.69

90820-2

Contactin-associated protein 2 Ab

PrThr

Pt

CSF

Ord

CBA IFA

SERO

1

Contactin-associated protein 2 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

CASPR2 Ab CSF Ql CBA IFA

null

ACTIVE

2.65

2.69

90821-0

Contactin-associated protein 2 Ab

Titr

Pt

CSF

Qn

CBA IFA

SERO

1

Contactin-associated protein 2 Ab [Titer] in Cerebral spinal fluid by Cell binding immunofluorescent assay

CASPR2 Ab Titr CSF CBA IFA

null

ACTIVE

2.65

2.69

90822-8

CV2 Ab

ACnc

Pt

CSF

Qn

Line blot

SERO

1

CV2 Ab [Units/volume] in Cerebral spinal fluid by Line blot

CV2 Ab CSF Line blot-aCnc

null

ACTIVE

2.65

2.7

90823-6

Dipeptidyl aminopeptidase-like protein 6 Ab

PrThr

Pt

CSF

Ord

CBA IFA

SERO

1

Dipeptidyl aminopeptidase-like protein 6 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

DPPX Ab CSF Ql CBA IFA

null

ACTIVE

2.65

2.69

90824-4

Dipeptidyl aminopeptidase-like protein 6 Ab

Titr

Pt

CSF

Qn

CBA IFA

SERO

1

Dipeptidyl aminopeptidase-like protein 6 Ab [Titer] in Cerebral spinal fluid by Cell binding immunofluorescent assay

DPPX Ab Titr CSF CBA IFA

null

ACTIVE

2.65

2.69

90825-1

Gamma aminobutyrate B receptor Ab

PrThr

Pt

CSF

Ord

CBA IFA

SERO

1

GABABR Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

GABABR Ab CSF Ql CBA IFA

null

ACTIVE

2.65

2.69

90826-9

Gamma aminobutyrate B receptor Ab

Titr

Pt

CSF

Qn

CBA IFA

SERO

1

GABABR Ab [Titer] in Cerebral spinal fluid by Cell binding immunofluorescent assay

GABABR Ab Titr CSF CBA IFA

null

ACTIVE

2.65

2.69

90827-7

Glial nuclear type 1 Ab

PrThr

Pt

CSF

Ord

IF

SERO

1

Glial nuclear type 1 Ab [Presence] in Cerebral spinal fluid by Immunofluorescence

Glial nuc type 1 Ab CSF Ql IF

null

ACTIVE

2.65

90828-5

Glial nuclear type 1 Ab

ACnc

Pt

CSF

Qn

Line blot

SERO

1

Glial nuclear type 1 Ab [Units/volume] in Cerebral spinal fluid by Line blot

Glial nuc type 1 Ab CSF Line blot-aCnc

null

ACTIVE

2.65

2.7

9082-9

Protein intake

MRat

8H

^Patient

Qn

null

IO_IN_SALTS+CALS

2

Protein intake 8 hour

Protein intake 8h

null

ACTIVE

1.0i

2.48

90829-3

Glutamate decarboxylase 65 Ab

ACnc

Pt

CSF

Qn

Line blot

SERO

1

Glutamate decarboxylase 65 Ab [Units/volume] in Cerebral spinal fluid by Line blot

GAD65 Ab CSF Line blot-aCnc

null

ACTIVE

2.65

2.7

90830-1

Leucine-rich glioma-inactivated protein 1 Ab

PrThr

Pt

CSF

Ord

CBA IFA

SERO

1

Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

LGI1 Ab CSF Ql CBA IFA

null

ACTIVE

2.65

2.69

90831-9

Leucine-rich glioma-inactivated protein 1 Ab

Titr

Pt

CSF

Qn

CBA IFA

SERO

1

Leucine-rich glioma-inactivated protein 1 Ab [Titer] in Cerebral spinal fluid by Cell binding immunofluorescent assay

LGI1 Ab Titr CSF CBA IFA

null

ACTIVE

2.65

2.69

90832-7

Ma+Ta Ab

PrThr

Pt

CSF

Ord

IF

SERO

1

Ma+Ta Ab [Presence] in Cerebral spinal fluid by Immunofluorescence

Ma+Ta Ab CSF Ql IF

null

ACTIVE

2.65

90833-5

Ma+Ta Ab

ACnc

Pt

CSF

Qn

Line blot

SERO

1

Ma+Ta Ab [Units/volume] in Cerebral spinal fluid by Line blot

Ma+Ta Ab CSF Line blot-aCnc

null

ACTIVE

2.65

2.7

90834-3

Myelin Ab

Titr

Pt

CSF

Qn

IF

SERO

1

Myelin Ab [Titer] in Cerebral spinal fluid by Immunofluorescence

Myelin Ab Titr CSF IF

null

ACTIVE

2.65

90835-0

Myelin associated glycoprotein Ab.IgM

PrThr

Pt

CSF

Ord

IB

SERO

1

Myelin associated glycoprotein IgM Ab [Presence] in Cerebral spinal fluid by Immunoblot

MAG IgM CSF Ql IB

null

ACTIVE

2.65

90836-8

Neuronal nuclear type 3 Ab

PrThr

Pt

CSF

Ord

IF

SERO

1

Neuronal nuclear type 3 Ab [Presence] in Cerebral spinal fluid by Immunofluorescence

Hu3 Ab CSF Ql IF

null

ACTIVE

2.65

9083-7

Protein intake

MRat

10H

^Patient

Qn

null

IO_IN_SALTS+CALS

2

Protein intake 10 hour

Protein intake 10h

null

ACTIVE

1.0i

2.48

90837-6

Neuronal nuclear type 3 Ab

Titr

Pt

CSF

Qn

IF

SERO

1

Neuronal nuclear type 3 Ab [Titer] in Cerebral spinal fluid by Immunofluorescence

Hu3 Ab Titr CSF IF

null

ACTIVE

2.65

90838-4

Neuronal nuclear type 3 Ab

ACnc

Pt

CSF

Qn

Line blot

SERO

1

Neuronal nuclear type 3 Ab [Units/volume] in Cerebral spinal fluid by Line blot

Hu3 Ab CSF Line blot-aCnc

null

ACTIVE

2.65

2.7

90839-2

N-methyl-D-aspartate receptor subunit 1 Ab

PrThr

Pt

CSF

Ord

CBA IFA

SERO

1

NMDAR subunit 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

NMDAR1 Ab CSF Ql CBA IFA

null

ACTIVE

2.65

2.69

908-4

Ax Ab

PrThr

Pt

Ser/Plas^BPU

Ord

null

BLDBK

1

Ax Ab [Presence] in Serum or Plasma from Blood product unit

Ax Ab SerPl BPU Ql

null

ACTIVE

1.0

2.56

90840-0

N-methyl-D-aspartate receptor subunit 1 Ab

Titr

Pt

CSF

Qn

CBA IFA

SERO

1

NMDAR subunit 1 Ab [Titer] in Cerebral spinal fluid by Cell binding immunofluorescent assay

NMDAR1 Ab Titr CSF CBA IFA

null

ACTIVE

2.65

2.69

90841-8

Purkinje cell cytoplasmic type 1 Ab

PrThr

Pt

CSF

Ord

IF

SERO

1

PCA-1 Ab [Presence] in Cerebral spinal fluid by Immunofluorescence

PCA-1 Ab CSF Ql IF

null

ACTIVE

2.65

90842-6

Purkinje cell cytoplasmic type 1 Ab

ACnc

Pt

CSF

Qn

Line blot

SERO

1

PCA-1 Ab [Units/volume] in Cerebral spinal fluid by Line blot

PCA-1 Ab CSF Line blot-aCnc

null

ACTIVE

2.65

2.7

90843-4

Purkinje cell cytoplasmic type 2 Ab

PrThr

Pt

CSF

Ord

IF

SERO

1

PCA-2 Ab [Presence] in Cerebral spinal fluid by Immunofluorescence

PCA-2 Ab CSF Ql IF

null

ACTIVE

2.65

90844-2

Purkinje cell cytoplasmic type Tr Ab

PrThr

Pt

CSF

Ord

CBA IFA

SERO

1

PCA-Tr Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

PCA-Tr Ab CSF Ql CBA IFA

null

ACTIVE

2.65

2.69

9084-5

Protein intake

MRat

12H

^Patient

Qn

null

IO_IN_SALTS+CALS

2

Protein intake 12 hour

Protein intake 12h

null

ACTIVE

1.0i

2.48

90845-9

Purkinje cell cytoplasmic type Tr Ab

PrThr

Pt

CSF

Ord

IF

SERO

1

PCA-Tr Ab [Presence] in Cerebral spinal fluid by Immunofluorescence

PCA-Tr Ab CSF Ql IF

null

ACTIVE

2.65

90846-7

Purkinje cell cytoplasmic type Tr Ab

Titr

Pt

CSF

Qn

CBA IFA

SERO

1

PCA-Tr Ab [Titer] in Cerebral spinal fluid by Cell binding immunofluorescent assay

PCA-Tr Ab Titr CSF CBA IFA

null

ACTIVE

2.65

2.69

90847-5

Zinc finger protein of the cerebellum 4 Ab

ACnc

Pt

CSF

Qn

Line blot

SERO

1

Zinc finger protein of the cerebellum 4 Ab [Units/volume] in Cerebral spinal fluid by Line blot

Zic4 Ab CSF Line blot-aCnc

null

ACTIVE

2.65

2.7

90848-3

Myelin associated glycoprotein-sulfated glucuronic paragloboside Ab.IgM

Titr

Pt

CSF

Qn

IA

SERO

1

Myelin associated glycoprotein/Sulfated glucuronic paragloboside IgM Ab [Titer] in Cerebral spinal fluid by Immunoassay

MAG/SGPG IgM Titr CSF IA

null

ACTIVE

2.65

90849-1

Cefpodoxime 4.0 ug/mL

Susc

Pt

Isolate

OrdQn

Method for Slow-growing mycobacteria

ABXBACT

1

Cefpodoxime 4 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria

Cefpodoxime 4 ug/mL Islt SlowMyco

null

ACTIVE

2.65

90850-9

cefTAZidime 1.0 ug/mL

Susc

Pt

Isolate

OrdQn

Method for Slow-growing mycobacteria

ABXBACT

1

cefTAZidime 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria

cefTAZidime 1 ug/mL Islt SlowMyco

null

ACTIVE

2.65

90851-7

GJB2 gene full mutation analysis

Find

Pt

Bld/Tiss

Doc

Sequencing

MOLPATH.MUT

1

GJB2 gene full mutation analysis in Blood or Tissue by Sequencing

GJB2 gene Full Mut Anl Bld/T Seq

null

ACTIVE

2.65

9085-2

Protein intake

MRat

24H

^Patient

Qn

null

IO_IN_SALTS+CALS

2

Protein intake 24 hour

Protein intake 24h

null

ACTIVE

1.0i

2.48

90852-5

Fax number

Tele

Pt

^Patient

Nom

null

ADMIN.PATIENT

2

Patient Fax number

Patient Fax #

null

ACTIVE

2.65

2.66

90853-3

Final score

Score

Pt

^Patient

Qn

DUKE-AD

SURVEY.DUKE-AD

4

Final score [DUKE-AD]

null

ACTIVE

2.65

90854-1

Duke Anxiety Depression Scale

-

Pt

^Patient

-

DUKE-AD

PANEL.SURVEY.DUKE-AD

4

Duke Anxiety Depression Scale [DUKE-AD]

null

ACTIVE

2.65

90855-8

Posterior inter-arch deviation

Type

Pt

Teeth and gum

Nom

null

DENTAL

2

Posterior inter-arch deviation Teeth and gum

Post inter-arch deviation Teeth+gum

null

ACTIVE

2.65

90856-6

Crossbite teeth

Num

Pt

Teeth and gum

Qn

null

DENTAL

2

Crossbite teeth [#]

Crossbite teeth

null

ACTIVE

2.65

90857-4

Closed-spaced teeth

Num

Pt

Teeth and gum

Qn

null

DENTAL

2

Closed-spaced teeth [#]

Closed-spaced teeth

null

ACTIVE

2.65

90858-2

Open-spaced teeth

Num

Pt

Teeth and gum

Qn

null

DENTAL

2

Open-spaced teeth [#]

Open-spaced teeth

null

ACTIVE

2.65

90859-0

Rotated teeth

Num

Pt

Teeth and gum

Qn

null

DENTAL

2

Rotated teeth [#]

Rotated teeth

null

ACTIVE

2.65

9086-0

Sodium intake

Sub

Pt

^Patient

Qn

Estimated

IO_IN_SALTS+CALS

2

Sodium intake Estimated

Sodium intake Est

null

ACTIVE

1.0i

2.48

90860-8

Crowded teeth

Num

Pt

Teeth and gum

Qn

null

DENTAL

2

Crowded teeth [#]

Crowded teeth

null

ACTIVE

2.65

90861-6

Missing teeth

Num

Pt

Teeth and gum

Qn

null

DENTAL

2

Missing teeth [#]

Missing teeth

null

ACTIVE

2.65

90862-4

Malocclusion index

Score

Pt

Teeth and gum

Qn

Calculated

DENTAL

2

Malocclusion index Teeth and gum Calculated

Malocclusion index Score Teeth+gum Calc

null

ACTIVE

2.65

90863-2

Labio-lingual spread

Len

Pt

Mouth

Qn

Measured

DENTAL

2

Labio-lingual spread [Length] Mouth Measured

Labio-lingual spread Mouth Measured

null

ACTIVE

2.65

90864-0

Dental abnormalities impacting orthodontic care

Find

Pt

Teeth and gum

Nom

null

DENTAL

2

Dental abnormalities impacting orthodontic care

Dental abnormalities orthodontic care

null

ACTIVE

2.65

90865-7

Craniofacial anomalies impacting orthodontic care

Find

Pt

Head

Nom

null

DENTAL

2

Craniofacial anomalies impacting orthodontic care

Craniofacial anomalies orthodontic care

null

ACTIVE

2.65

90866-5

Orthodontic preconditions

Find

Pt

^Patient

Nom

null

DENTAL

2

Orthodontic preconditions

null

ACTIVE

2.65

90867-3

Airway problem impacting orthodontic treatment

Type

Pt

^Patient

Nom

null

DENTAL

2

Airway problem impacting orthodontic treatment

Airway prob impact orthodont trtmt

null

ACTIVE

2.65

90868-1

Orthognathic surgery consideration summary

Find

Pt

^Patient

Nar

null

DENTAL

2

Orthognathic surgery consideration summary Narrative

Orthognathic surg consideration summary

null

ACTIVE

2.65

90869-9

Asymmetry of lower face

Find

Pt

Face

Nom

null

DENTAL

2

Asymmetry of lower face

null

ACTIVE

2.65

90870-7

Habits impacting orthodontic condition

Type

Pt

^Patient

Nom

null

DENTAL

2

Habits impacting orthodontic condition

Habits impact orthodontic cond

null

ACTIVE

2.65

90871-5

Medical conditions impacting orthodontic condition

Hx

Pt

^Patient

Nom

null

DENTAL

2

History of Medical conditions impacting orthodontic condition

Hx of Med cond impact orthodontic cond

null

ACTIVE

2.65

90872-3

Supplemental information about orthodontic condition

Find

Pt

Oral cavity

Doc

null

DENTAL

2

Supplemental information about orthodontic condition Oral cavity Document

Info orthodontic cond Oral cavity Doc

null

ACTIVE

2.65

90873-1

Malocclusion severity assessment

Find

Pt

Teeth and gum

Doc

null

DOC.MISC

2

Malocclusion severity assessment

Malocclusion severity assess Doc

null

ACTIVE

2.65

90874-9

Orthodontic evaluation summary

Find

Pt

^Patient

Doc

null

DOC.MISC

2

Orthodontic evaluation summary Document

Orthodontic eval summary Doc

null

ACTIVE

2.65

90875-6

Orthodontic service attachment

Find

Pt

{Setting}

Doc

{Role}

DOC.ADMIN

2

Orthodontic service attachment

Orthodontic service attach

null

ACTIVE

2.65

2.67

90876-4

Progress note

Find

Pt

{Setting}

Doc

Thromboembolism

DOC.ONTOLOGY

2

Thromboembolism Progress note

Thromboemb Prog note

null

ACTIVE

2.65

2.73

90877-2

Procedure note

Find

Pt

{Setting}

Doc

Thromboembolism

DOC.ONTOLOGY

2

Thromboembolism procedure note

Thromboemb Procedure note

null

ACTIVE

2.65

9087-8

Sodium intake

Sub

Pt

^Patient

Qn

Measured

IO_IN_SALTS+CALS

2

Sodium intake Measured

null

ACTIVE

1.0i

2.48

90878-0

Note

Find

Pt

Telephone encounter

Doc

Thromboembolism

DOC.ONTOLOGY

2

Thromboembolism Telephone encounter Note

Thromboemb Phone Note

null

ACTIVE

2.65

90879-8

Conference note

Find

Pt

{Setting}

Doc

Thromboembolism.team

DOC.ONTOLOGY

2

Thromboembolism Team Conference note

Thromboemb Team Conf eval note

null

ACTIVE

2.65

90880-6

Arachis hypogaea recombinant (rAra h) 6 Ab.IgE

ACnc

Pt

Ser

Qn

null

ALLERGY

1

Peanut recombinant (rAra h) 6 IgE Ab [Units/volume] in Serum

Peanut (rAra h) 6 IgE Qn

null

ACTIVE

2.65

2.73

90881-4

(Alternaria tenuis+Artemisia vulgaris+Betula verrucosa+Cladosporium herbarum+Phleum pratense) Ab.IgE

PrThr

Pt

Ser

Ord

Multidisk

ALLERGY

1

Inhalant Allergen Mix 6 (Alternaria tenuis+Mugwort+Silver birch+Cladosporium herbarum+Timothy grass) IgE Ab [Presence] in Serum by Multidisk

Inhalant Allerg Mix 6 IgE Ql

null

ACTIVE

2.65

90882-2

Staphylococcus aureus enterotoxin E Ab.IgE.RAST class

PrThr

Pt

Ser

Ord

null

ALLERGY

1

Staphylococcus aureus enterotoxin E IgE Ab RAST class [Presence] in Serum

S aureus Etx E IgE RAST Ql

null

ACTIVE

2.65

90883-0

PROMIS pediatric item bank - mobility - version 2.0

-

Pt

^Patient

-

PROMIS.PEDS

PANEL.SURVEY.PROMIS

4

PROMIS pediatric item bank - mobility - version 2.0

null

Copyright © 2010 PROMIS Health Organization or other individuals/entities that have contributed information and materials to Assessment Center, and are being used with the permission of the copyright holders. Use of PROMIS instruments (e.g., item banks, short forms, profile measures) are subject to the PROMIS Terms and Conditions available at: http://www.assessmentcenter.net/TandC.aspx

ACTIVE

2.65

90884-8

PROMIS pediatric mobility - version 2.0 T-Score

Tscore

Pt

^Patient

Qn

PROMIS.PEDS

SURVEY.PROMIS

4

PROMIS pediatric mobility - version 2.0 T-score

null

Copyright © 2010 PROMIS Health Organization or other individuals/entities that have contributed information and materials to Assessment Center, and are being used with the permission of the copyright holders. Use of PROMIS instruments (e.g., item banks, short forms, profile measures) are subject to the PROMIS Terms and Conditions available at: http://www.assessmentcenter.net/TandC.aspx

ACTIVE

2.65

90885-5

Influenza virus D RNA

ThreshNum

Pt

XXX

Qn

Probe.amp.tar

MICRO

1

Influenza virus D RNA [Cycle Threshold #] in Specimen by NAA with probe detection

FLUDV RNA Ct Spec Qn NAA+probe

null

ACTIVE

2.65

2.69

9088-6

Sodium intake

SRat

1H

^Patient

Qn

null

IO_IN_SALTS+CALS

2

Sodium intake 1 hour

Sodium intake 1h

null

ACTIVE

1.0i

2.48

90886-3

Influenza virus B RNA

ThreshNum

Pt

XXX

Qn

Probe.amp.tar

MICRO

1

Influenza virus B RNA [Cycle Threshold #] in Specimen by NAA with probe detection

FLUBV RNA Ct Spec Qn NAA+probe

null

ACTIVE

2.65

2.69

90887-1

Porcine circovirus type 3 ORF2 gene

Seq

Pt

Isolate

Nom

Sequencing

MICRO

1

Porcine circovirus type 3 ORF2 gene [Nucleotide sequence] in Isolate by Sequencing

PCV 3 ORF2 gene Islt-Seq

null

ACTIVE

2.65

90888-9

Porcine circovirus type 3 DNA

NCnc

Pt

XXX

Qn

Probe.amp.tar

MICRO

1

Porcine circovirus type 3 DNA [#/volume] (viral load) in Specimen by NAA with probe detection

PCV3 DNA # Spec NAA+probe

null

ACTIVE

2.65

2.69

90889-7

Porcine circovirus type 2 Ab.IgG

Titr

Pt

XXX

Qn

IF

MICRO

1

Porcine circovirus type 2 IgG Ab [Titer] in Specimen by Immunofluorescence

PCV2 IgG Titr Spec IF

null

ACTIVE

2.65

2.69

90890-5

Benzodiazepines panel

-

Pt

Urine

-

Confirm

PANEL.DRUG/TOX

1

Benzodiazepines panel - Urine by Confirmatory method

Benzodiazepines Pnl Ur Cfm

null

ACTIVE

2.65

90891-3

Estradiol^2H post XXX challenge

MCnc

Pt

Ser/Plas

Qn

null

CHAL

1

Estradiol (E2) [Mass/volume] in Serum or Plasma --2 hours post XXX challenge

Estradiol 2h p chal SerPl-mCnc

null

ACTIVE

2.65

90892-1

Borrelia sp panel

-

Pt

Bld

-

Non-probe.amp.tar

PANEL.MICRO

1

Borrelia sp panel - Blood by NAA with non-probe detection

B sp panel Bld NAA+non-probe

null

ACTIVE

2.65

2.68

90893-9

Borrelia burgdorferi bba64 gene

PrThr

Pt

Bld

Ord

Non-probe.amp.tar

MICRO

1

Borrelia burgdorferi bba64 gene [Presence] in Blood by NAA with non-probe detection

B burg bba64 gene Bld Ql NAA+non-probe

null

ACTIVE

2.65

9089-4

Sodium intake

SRat

8H

^Patient

Qn

null

IO_IN_SALTS+CALS

2

Sodium intake 8 hour

Sodium intake 8h

null

ACTIVE

1.0i

2.48

90894-7

Noroxymorphone

MCnc

Pt

Urine

Qn

Confirm

DRUG/TOX

1

Noroxymorphone [Mass/volume] in Urine by Confirmatory method

Noroxymorphone Ur Cfm-mCnc

null

ACTIVE

2.65

90895-4

Task identifier

ID

Pt

^Event

Nom

null

ADMIN.ID

2

Task identifier

Task ID

null

ACTIVE

2.65

2.68

90896-2

Person assigned to task

Pn

Pt

Personnel

Nom

null

ADMIN

2

Personnel Person assigned to task

null

ACTIVE

2.65

2.68